Grayscale likely to launch HYPE ETF in U.S. with 0.29% fee
Analyst James Seyffart posted that Grayscale is likely to launch a HYPE ETF in the U.S. this week after adding ticker HYPG and a 0.29% fee to its filing.
Grayscale is expected to begin trading a HYPE exchange-traded fund in the U.S. this week after the firm amended its regulatory filing to add the ticker HYPG and a 0.29% management fee, analyst James Seyffart posted on X, calling the launch “likely imminent” and “expecting the launch this week.”
The amendment is the sixth revision to the filing and specifies a 0.29% annual fee. That fee is slightly lower than competing Hyperliquid-linked ETFs: 21Shares charges 0.30% and Bitwise charges 0.34%.
The 21Shares and Bitwise HYPE ETFs began trading in mid-May and have drawn nearly $140 million in combined net inflows since their launches. Grayscale’s filing indicates the fund would stake HYPE tokens to earn yield, following the same structure used by those existing funds.
On-chain data show Hyperliquid routinely handles more than $170 billion in monthly trading volume across several asset classes. HYPE reached a record price of $75.30 on Monday, lifting its market capitalization to about $16.7 billion and placing it near the 10th-largest cryptocurrency by market value.
The potential Grayscale listing comes as U.S.-listed Bitcoin ETFs have recorded net outflows for more than 10 consecutive trading days, totaling close to $3 billion, and U.S. Ether ETFs are on a 14-day net outflow streak. These movements have changed capital flows within the crypto ETF market.
Market participants are awaiting an official listing notice and the fund’s first-day trading and inflow data to confirm launch details and initial investor demand.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.
Articles by this author
